SILEXION THERAPEUTICS CORP (SLXN) Stock Analyst Ratings
USA - NASDAQ:SLXN - KYG1281K1307 - Common Stock
3.3 USD
-0.14 (-4.07%)
3.4296 USD
+0.13 (+3.93%)
ChartMill assigns a Buy % Consensus number of 83% to SLXN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.48. This target is 641.82% above the current price.
SLXN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SLXN.
In the previous month the buy percentage consensus was at a similar level.
SLXN was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-20 | Maxim Group | Maintains | Buy -> Buy |
| 2024-11-01 | Maxim Group | Initiate | Buy |
SILEXION THERAPEUTICS CORP / SLXN FAQ
What is the average price target for SILEXION THERAPEUTICS CORP (SLXN) stock?
7 analysts have analysed SLXN and the average price target is 24.48 USD. This implies a price increase of 641.82% is expected in the next year compared to the current price of 3.3.
What is the consensus rating for SLXN stock?
The consensus rating for SILEXION THERAPEUTICS CORP (SLXN) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed SILEXION THERAPEUTICS CORP (SLXN)?
The number of analysts covering SILEXION THERAPEUTICS CORP (SLXN) is 7.